Magnesium salicylate

Magnesium salicylate

Magnesium salicylate is a common analgesic and non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate muscular pain. It is also used to treat headaches, general back pain, and certain joint pains like arthritis.

It is found in a variety of over-the-counter (OTC) medications as an anti-inflammatory, primarily for back-pain relief. Magnesium salicylate can be an effective OTC alternative to prescription NSAIDs, with both anti-inflammatory and pain-relieving effects.

Though the recommended dosage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 467.2 mg anhydrous magnesium salicylate), effective pain relief is often found with a half dosage, with reduced anti-inflammatory results. note: Doan's extra strength OTC dose is 2 x 580 mg magnesium salicylate tetrahydrate every 6 hours, equivalent to 934.4 mg of anhydrous magnesium salicylate .

Brand names

  • Doan's, Original (OTC), originally manufactured by by the Campana Corporation of Batavia, Illinois; subsequently,a division of Dow Chemical and thereafter a division of Purex, Inc; it was well after that Novartis Consumer Health, Inc. manufactured Doan's Pills
  • Extra Strength Doan's (OTC), first manufactured by Campana and later by, among others,Novartis Consumer Health, Inc.
  • Momentum (OTC)- this is now marketed as Percogesic (OTC)
  • Arthriten (OTC)
  • Keygesic-10 (Rx)
  • Mobidin (Rx)
  • Novasal (Rx)

Controversy

While magnesium salicylate is an alternative for pain relief, it still is an NSAID like others in its category, without any proven superiority over other over the counter type pain relievers (NSAID).

Doan's specifically, and the company producing it, Novartis, have been tried over their claim that the product is superior in providing pain relief. In June 1996, The FTC, Federal Trade Commission charged the company with violating federal law with its unsubstantiated claim. In March 1998, the court ruled in favor of the FTC but there was no stipulation about how the company should or would have to mend its advertising/packaging[1]. Thus, Doan's is still marketed as a "superior treatment for back pain".

References

Notes
  1. ^ http://www.ftc.gov/opa/1999/05/doans.shtm Doan's Pills Must Run Corrective Advertising: FTC Ads Claiming Doan's Is Superior In Treating Back Pain Were Unsubstantiated


v · Salicylates
Salicylic acid • Aspirin • Aloxiprin • Methyl salicylate • Magnesium salicylate • Ethyl salicylate • Bismuth subsalicylate • Sodium salicylate • Salicylamide • Salicin • Benorilate • Salsalate • Ethenzamide • Diflunisal • Trolamine salicylate • Homosalate • Salicylmethylecgonine • Octyl salicylate • Aluminon • Benzyl salicylate • Copper aspirinate • Potassium salicylate
v · d · eAnti-inflammatory products (M01A)
Pyrazolidine/Butylpyrazolidines
Acetic acid derivatives
and related substances
Oxicams
Propionic acid derivatives
Fenamates
Coxibs
Other

M: MUS, DF+DRCT

anat (h/n, u, t/d, a/p, l)/phys/devp/hist

noco(m, s, c)/cong(d)/tumr, sysi/epon, injr

proc, drug (M1A/3)
v · d · eNon-steroidal anti-inflammatory drug (NSAID) products (primarily M01A and M02A, also N02BA)
Salicylates
Aspirin (acetylsalicylic acid) • Aloxiprin • Benorylate • Diflunisal • Ethenzamide • Magnesium salicylate • Methyl salicylate • Salsalate • Salicin • Salicylamide • Sodium salicylate
Arylalkanoic acids
2-Arylpropionic acids
(profens)
N-Arylanthranilic acids
(fenamic acids)
Pyrazolidine derivatives
Oxicams
COX-2 inhibitors
Celecoxib • Deracoxib‡ • Etoricoxib • Firocoxib‡ • Lumiracoxib† • Parecoxib • Rofecoxib† • Valdecoxib†
Sulfonanilides
Topically used products
COX-inhibiting nitric oxide donators
Others
Items listed in bold indicate initially developed compounds of specific groups. †Withdrawn drugs. ‡Veterinary use medications.


Stub icon This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. This analgesic-related article is a stub. You can help Wikipedia by expanding it.